The Triumph of Innovation and the Hard Work of Caring for Patients With Diabetes

In this issue, Zaccardi and colleagues' network meta-analysis summarizes evidence about the efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists. The editorialists discuss the findings and how the lack of high-quality comparative effectiveness data makes choosing from among the growing number of diabetes treatment options a difficult task.

from Medicine via xlomafota13 on Inoreader http://ift.tt/1jKVkvz
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OMrjZj
via IFTTT